PubMed Health⌕ Search

Biomedical subjects

M Kobisch

Publications and source records attributed to M Kobisch.

At least 37 records · Page 2Linked to original sources

Use of an internal control in a nested-PCR assay for Mycoplasma hyopneumoniae detection and quantification in tracheobronchiolar washings from pigs.

We have previously reported a nested PCR assay for the detection of Mycoplasma hyopneumoniae directly in tracheobronchiolar washings from living pigs in field conditions. Here, we describe the construction and use of an internal control to monitor the presence of PCR inhibitors. A PCR modified target DNA was constructed by insertion of a small DNA fragment into the M. hyopneumoniae specific DNA target. We have demonstrated that the internal control failed to be amplified in only three tracheobronchiolar washings samples out of the 362 tested. This control molecule was inserted in a Spiroplasma citri derived plasmid vector and introduced into S. citri cells by electroporation. After a few passages we ensured that the recombinant plasmid became inserted into the genome of S. citri. PCR amplification of the DNA of this transformed S. citri strain using nested PCR primers led to amplification of a 900-bp fragment which can be discriminated from the M. hyopneumoniae PCR product 700 bp. The S. citri transformants with the integrated internal control were added to the tracheobronchiolar washings prior to PCR and used as an internal control to check the efficiency of sample processing, and to demonstrate the presence of inhibitors. Furthermore, we have been able to estimate the number of mycoplasma cells in the tracheobronchiolar washings. Quantitation was performed by comparing the PCR signal intensity of the specific M. hyopneumoniae template with known concentrations of the S. citri competitor. The titer in tracheobronchiolar washings ranged approximatively from 10(4)to 10(8)M. hyopneumoniae cells per ml of clinical specimen. Quantitative PCR can be a useful tool for monitoring the progression of M. hyopneumoniae in the disease process.

Animals↗

Isolation and characterization of a capsule-deficient mutant of Actinobacillus pleuropneumoniae serotype 1.

The capsular polysaccharides (CPS) play a major role in pathogenicity of Actinobacillus pleuroIpneumoniae, the causative agent of porcine pleuropneumonia. The purpose of the present study was to isolate a mutant in CPS biosynthesis by using a mini-Tn 10 transposon mutagenesis system and evaluate its adherence to host cells. One mutant apparently did not possess CPS as it did not react with a monoclonal antibody against A. pleuropneumoniae serotype 1 capsular antigen. Absence of capsule was confirmed by flow cytometry and also by transmission electron microscopy after polycationic ferritin labelling. The site of insertion of the mini-Tn 10 was determined and found to be in the cpxC gene. Its gene product, CpxC, is a protein involved in polysaccharide transport across the cytoplasmic membrane during CPS biosynthesis. Use of piglet tracheal frozen sections indicated that the CPS mutant adhered significantly (P=0.0001) more than the parent strain. The non-capsular mutant was less virulent in pigs compared to the parent strain and showed no mortality in experimentally infected pigs. The CPS mutant was however resistant to pig serum. This CPS mutant is the first A. pleuropneumoniae mutant in a CPS transport gene. It is also the first time that adherence of a CPS mutant of A. pleuropneumoniae is evaluated. Our observations indicate that capsular polysaccharides of A. pleuropneumoniae serotype 1 are not involved in adherence to piglet tracheal frozen sections but rather mask, at least in part, the adhesive functions.

Actinobacillus Infections↗

Experimental aerosol transmission of Actinobacillus pleuropneumoniae to pigs.

In order to demonstrate the possible role of aerosol in the transmission of Actinobacillus pleuropneumoniae, an experiment including 18 specific pathogen-free (SPF), 10-week-old piglets, randomly distributed into 2 adjacent units, was carried out. In these facilities, air was forced through absolute filters to prevent any contact with infectious agents. During the first 6 d post inoculation, the 2 units were connected by a rectangular opening and the air circulation was forced by the ventilation system from unit A (inoculated pigs) to unit B (non-inoculated pigs). The A. pleuropneumoniae strain (biovar 1 serovar 9) was isolated in France from an outbreak of porcine pleuropneumonia. Two different infecting doses, 10(7) cfu/animal and 10(8) cfu/animal, were inoculated by intranasal route in 6 pigs of unit A. The infection spread quickly from the inoculated pigs to the non-inoculated pigs. Clinical signs were acute during the 4 d post inoculation: hyperthermia, respiratory distress and, sometimes, death (6 pigs of the unit A and 2 pigs of the unit B). All pigs seroconverted against A. pleuropneumoniae serovar 9 within 2 weeks. Lung lesions were severe: fibrinous pleurisy and lung hemorrhages in the acute stage, pleural adherences and focal pulmonary necrosis in the chronic stage. Actinobacillus pleuropneumoniae was isolated from the tonsils and/or lungs in 16 animals. It could be also isolated from the air of the experimental unit. This study showed that A. pleuropneumoniae was readily transmitted through aerosol over a distance of at least 2.5 m.

Actinobacillus Infections↗

Isolation and characterization of mini-Tn10 lipopolysaccharide mutants of Actinobacillus pleuropneumoniae serotype 1.

Lipopolysaccharide (LPS) has previously been identified as the major adhesin of Actinobacillus pleuropneumoniae involved in adherence to porcine respiratory tract cells. The purpose of the present study was to isolate and characterize mutants in LPS biosynthesis by using a mini-Tn10 transposon mutagenesis system. Seven mutants appeared to possess a rough LPS (among which two had similar Southern blot profiles) while one mutant (#5.1) expressed the high-molecular-mass LPS, but as visualized by Tricine SDS-PAGE, showed an additional band in the core-lipid A region. The LPS mutants showed sensitivity to pig serum to various degrees, while the parent strain was serum-resistant. Use of piglet frozen tracheal sections indicated that, surprisingly, the rough LPS mutants adhered similarly or in greater numbers than the parent strain. However, the LPS mutant #5.1 adhered significantly less than the parent strain and was also less virulent in pigs. The gene affected by mini-Tn10 in LPS mutant #5.1 is galU, the structural gene for UTP-alpha-D-glucose-1-phosphate uridylyltransferase, involved in LPS core biosynthesis. Complementation analysis confirmed that the phenotypic characteristics of LPS mutant #5.1 are the result of the inactivation of the galU gene. Our data suggest that although the presence of O-antigen does not seem to be essential, an intact core-lipid A region might be required for adherence of A. pleuropneumoniae to porcine respiratory tract cells. To the best of our knowledge, these mutants represent the first isogenic mutants of A. pleuropneumoniae defective in LPS biosynthetic genes.

Actinobacillus Infections↗

Genomic relatedness among Actinobacillus pleuropneumoniae field strains of sterotypes 1 and 5 isolated from healthy and diseased pigs.

Forty-four Actinobacillus pleuropneumoniae isolates recovered from both healthy and diseased pigs were characterized by random amplified polymorphic DNA analysis (RAPD), pulsed field gel electrophoresis (PFGE) and apx toxin gene typing. Nine RAPD types and 14 PFGE patterns were identified. No common RAPD or PFGE patterns were found between strains of serotype 1 and those of serotype 5. The RAPD analysis indicated that the 15 serotype 1 strains isolated from diseased pigs were assigned to 4 RAPD types, with 66% of strains characterized by the same RAPD type. By contrast, the 5 strains of serotype 1 isolated from healthy carriers were dispersed in 4 RAPD types. These data suggest that the diversity of strains isolated from healthy pigs could be higher than that of strains recovered from diseased pigs. In addition, all serotype 5 strains exhibited a unique RAPD type. Unlike RAPD, PFGE analysis allowed discrimination among isolates of serotype 1 and among those of serotype 5. All but 3 isolates showed the same apx genotype as their respective serotype reference strain. These data indicate that RAPD analysis is a valuable rapid tool for routine subtyping of strains of serotype 1. For strains of serotype 5, a combination of several typing methods, such as PFGE and apx gene typing, is needed to provide useful information on the molecular epidemiology of swine pleuropneumonia.

Actinobacillus Infections↗

Chromosome sizes and phylogenetic relationships between serotypes of Actinobacillus pleuropneumoniae.

The genome size of Actinobacillus pleuropneumoniae was determined by pulsed field gel electrophoresis of AscI and ApaI digested chromosomal DNA. The genome size of the type strain 4074T (serotype 1) was determined to be 2404 +/- 40 kb. The chromosome sizes for the reference strains of the other serotypes range between 2.3 and 2.4 Mb. The restriction pattern profiles of AscI, ApaI and NheI digested chromosomes showed a high degree of polymorphism among the different serotype reference strains and allowed their discrimination. The analysis of the macrorestriction pattern polymorphism revealed phylogenetic relationships between the different serotype reference strains which reflect to some extent groups of serotypes known to cross-react serologically. In addition, different pulsed fields gel electrophoresis patterns also revealed heterogeneity in the chromosomal structure among different field strains of serotypes 1, 5a, and 5b, while strains of serotype 9 originating from most distant geographical places showed homogeneous ApaI patterns in pulsed field gel electrophoresis.

Actinobacillus pleuropneumoniae↗

Polymerase chain reaction for Mycoplasma hyopneumoniae detection in tracheobronchiolar washings from pigs.

We have used the polymerase chain reaction (PCR) to detect Mycoplasma hyopneumoniae in tracheobronchiolar washings collected from experimentally infected piglets. On the basis of the published nucleotide sequence of M. hyopneumoniae I141 probe (accession number U02537), primers were chosen to produce an amplified fragment of 1561 bp. All the M. hyopneumoniae strains tested could be detected by the PCR test. DNA from other mycoplasmal and bacterial species currently isolated from respiratory tract of piglets gave negative result. The detection limit was estimated to be 500 fg of purified DNA corresponding to 4.10(2) organisms. The sensitivity of PCR reaction was also evaluated on microorganisms in culture, the limit sensitivity was 2.5 10(3) organisms. In the present study, a total of 143 tracheobronchiolar washings collected from experimentally infected piglets were submitted to PCR. For each tracheobronchiolar washing, PCR was performed on crude extracts treated with lysis buffer and on extracted DNA. The PCR results obtained with the two kinds of samples were compared to the immunofluorescence (IF) results. This comparison indicates a good correlation between PCR and IF test in 121/143 cases. The presence of M. hyopneumoniae is revealed in 19/143 of the washing samples only by PCR. In our hand, PCR appears to be the more sensitive test to detect M. hyopneumoniae in experimentally infected piglets.

Animals↗

Detection of antibodies against Streptococcus suis capsular type 2 using a purified capsular polysaccharide antigen-based indirect ELISA.

In the present study a purified capsular polysaccharide antigen-based indirect ELISA (CPS-ELISA) to detect antibodies against Streptococcus suis capsular type 2 was developed and compared with a whole cell antigen-based ELISA (WCA-ELISA). The WCA-ELISA presented a very low specificity when rabbit antisera to other capsular types were tested. Most of these cross-reactions were due to common proteins. The standardized CPS-ELISA gave satisfactory results using a concentration of 0.1 micrograms/well; most cross-reactions decreased significantly, with some exceptions, such as those shared by capsular types 1/2, 12 and 17. These cross-reactions were mainly due to common epitopes present in the capsule, as shown by immunoblotting. In a second experiment, the CPS-ELISA was used to detect antibodies in experimentally infected piglets. Despite the fact that capsular type 2 S. suis could be reisolated from all infected animals during and/or after the trial, antibody titers against a second infection. Sera from piglets experimentally infected were completely protected against a second infection. Sera from piglets experimentally infected with S. suis capsular types 1/2 or 12 presented cross-reactions at low dilutions, confirming data previously obtained with rabbit sera. Finally, sera of animals from herds with clinical signs associated with S. suis capsular type 2 did not present titers significantly different from those of disease free herds. From our results we concluded that the CPS-ELISA developed in this study can not be used as a diagnostic tool to identify infected animals.

Animals↗

Analysis of putative ABC transporter genes in Mycoplasma hyopneumoniae.

A previously described DNA probe specific for Mycoplasma hyopneumoniae (I-141) was fully sequenced and found to consist of 1618 bp and to contain two tandemly repeated ORFs. The deduced amino acid sequence of the two ORFs showed significant homologies with ATP-binding cassette (ABC) transporter proteins, particularly those of the eukaryotic multidrug resistance (MDR) protein family (up to 21% identity and 47% similarity). A somewhat lower homology was evident with the secretion protein HlyB of the RTX-haemolysin from Escherichia coli. The location of the two ORFs on the M. hyopneumoniae chromosome was downstream of the rrl gene encoding the 23S rRNA, but transcribed in the opposite direction. PCR amplification and subsequent chromosomal analysis by Southern blot hybridization of several M. hyopneumoniae strains showed that all field strains contained the two putative ABC transporter genes. However, some culture collection strains derived from strain J had lost these genes as the result of a 2221 bp deletion.

ATP-Binding Cassette Transporters↗

Role of capsular sialic acid in virulence and resistance to phagocytosis of Streptococcus suis capsular type 2.

Streptococcus suis capsular type 2 has a capsule rich in sialic acid (NANA). Sialic acid, known to be an antiphagocytic factor for many bacterial species, inhibits the activation of the alternative complement pathway. The role of capsular NANA in virulence, resistance to phagocytosis and intracellular survival of S. suis capsular type 2 was evaluated. In general, a low concentration of NANA was observed for all the S. suis strains tested. In addition, no difference could be found in NANA concentrations between strains of different virulence degrees. Sialic acid concentration increased in the virulent strain 89-1591 and the avirulent strain 90-1330 after in vivo growth with an increased capsular material thickness compared to growth in vitro. No significant difference could be found in the phagocytosis rate by porcine blood monocytes of either strain and strain 89-1591 treated with sialidase or the sialic acid-binding lectin from Sambucus nigra (SNA I). Intracellular survival of strain 89-1591 decreased after treatments with sialidase or lectin, becoming comparable to that of strain 90-1330. Finally, no difference could be seen in virulence using a murine model, even if strain 89-1591 was treated with the enzyme or the lectin. Thus, NANA does not seem to be a critical virulence factor for S. suis capsular type 2.

Animals↗

Swine mycoplasmoses.

Mycoplasma hyopneumoniae is the primary agent of enzootic pneumonia in pigs. The lung lesions, generally observed in young pigs, are characterised by a hyperplasia of the epithelial cells and an increased perivascular and peribronchiolar accumulation of mononuclear cells. Following M. hyopneumoniae infection, immune reactions are observed and resistance is induced in pigs. Laboratory diagnosis is generally performed by an immunofluorescent test and by enzyme-linked immunosorbent assay. Antibiotics are useful but the development of resistance has been described. Vaccination seems to be an effective method of controlling the disease. M. hyorhinis, generally transmitted by sows to piglets through nasal secretions, exists in a high percentage in the respiratory tract of healthy pigs. But some strains can induce serofibrinous to fibrinopurulent polyserositis and arthritis. M. hyorhinis is isolated from acute and subacute phase lesions and serum antibodies are detectable. M. hyosynoviae has a special affinity for joint tissue and may cause arthritic disease, leading to economic losses. This mycoplasma is generally located in the tonsils. Piglets are infected by sows after four to six weeks of life. Evidence of disease occurs in animals of between 30 to 40 kg and 100 kg, and bursae and joints are affected. A non-suppurative viscous fluid of a serofibrinous/serosanguineous nature is reported. In chronic cases, the synovial membrane is affected. M. hyosynoviae is isolated from the joints and pharyngeal/tonsillar samples and can induce antibodies in blood and joint fluid. Predisposing factors play an important role. M. flocculare is widely distributed in swine, in normal and pneumonic lungs and in nasal cavities, but no pathogenic capability has been described. There is great interest in this mycoplasma because of the great similarity to M. hyopneumoniae.

Animals↗

[Comparison of the use of a vaccine and sequential antibiotic treatment in a herd infected with Mycoplasma hyopneumoniae].

The purpose of this study was to compare the efficacy of Mycoplasma hyopneumoniae vaccination with pulse medication in a pig herd chronically infected with Mycoplasma hyopneumoniae. Control groups of pigs were compared to vaccinated or treated groups. Medication and vaccination induced a significant reduction of pneumonia score (46.37% and 29.8% respectively, compared to 53.85% for control groups, p < 0.05). The treatment did not induce a significant reduction of the mean range of lung lesions (3.75) compared to the control groups (4.25). The mean range of lung lesions was significantly reduced by vaccine (3.06, p < 0.005) but not by treatment. Neither the medication nor the vaccination were able to clear M hyopneumoniae or Pasteurella multocida from lung tissue. In this herd, the vaccination had a beneficial effect on daily weight gain of pigs (695.9 g/day compared to 683.1 g/day for the control groups). The improvement of the age at slaughtering was 1.3 days for treated groups and 2.4 days for vaccinated groups compared to control groups. The vaccination induced a significant improvement in muscle rate (57.05%) compared to control groups (56.41%, p < 0.05) and to treated groups (56.21%, p < 0.001). In this herd infected with M hyopneumoniae, after allowing for treatment cost, manpower excepted, the increase in value was from -3 FF to -11 FF for the antibiotic treatment and +10.4 FF for the vaccination. From economical and medical points of view, the vaccination was preferable to the treatment under the conditions described in this study.

Animals↗

Immune response against the L-lactate dehydrogenase of Mycoplasma hyopneumoniae in enzootic pneumonia of swine.

The L-lactate dehydrogenase (LDH) of Mycoplasma hyopneumoniae, formerly named protein P36, belongs to the predominant immunogenic proteins in pigs which were naturally or experimentally infected with M. hyopneumoniae. The antigenic reaction against M. hyopneumoniae LDH has been shown to be species specific. Recombinant M. hyopneumoniae LDH, which was genetically engineered to contain six histidine residues at its C-terminal end, was expressed in E. coli and purified to a high degree using Ni-chelate affinity chromatography. The genetically engineered LDH still showed the same biochemical activity and immunological specificity as the wild-type LDH and was used as an antigen for a M. hyopneumoniae LDH ELISA. Using this assay, we showed that pigs experimentally infected with M. hyopneumoniae raised antibodies against LDH in two steps. An early, relatively weak anti-LDH response was detected between 5 to 10 weeks post-infection when clinical signs and lung lesions occur. This first minor raise of anti-LDH antibodies occurred simultaneously with the strong appearance of antibodies against an antigen consisting of membrane proteins of M. hyopneumoniae prepared with Tween 20 extraction. A second, strong raise in anti-LDH antibodies was observed from the twelfth week after infection, at a time when the disease signs and the infectious agent disappeared. The high anti-LDH titer persisted until 21 weeks post-infection, in contrast to the antibody titer against the membrane proteins which started to decrease after its peak at 12 weeks post-infection. A LDH-ELISA may also be useful for detecting past infections.

Amino Acid Sequence↗

A blocking ELISA using a monoclonal antibody for the serological detection of Mycoplasma hyopneumoniae.

A blocking ELISA was developed by using a monoclonal antibody (4082-05-344-18) which specifically detected an epitope on the Mycoplasma hyopneumoniae 40 kDa membrane protein without cross-reacting with M flocculare or M hyorhinis. The results obtained with sera from specific pathogen-free pigs inoculated with M flocculare or M hyorhinis confirmed the specificity of the assay. An immunoblotting procedure was used to characterise the antibody response of pigs experimentally infected with M hyopneumoniae. Antibodies to the 40 kDa antigen were detected two weeks after infection and remained as major markers for at least 20 weeks. Cross-reacting antibodies to this antigen were not detected in convalescent sera from piglets infected with M flocculare or M hyorhinis. Sera from experimentally infected pigs were compared by means of the blocking ELISA and an indirect ELISA. The kinetics of ELISA antibodies after experimental inoculation were also studied. The detection of antibody was rather more stable for a longer time with the blocking ELISA than with the indirect ELISA. In an evaluation of more than 1000 sera from the field there was excellent agreement between the two methods.

Aging↗

Serological characterisation of Actinobacillus pleuropneumoniae strains of serotypes 1, 9 and 11.

Various serological tests such as agglutination, coagglutination, indirect haemagglutination, immunodiffusion and counterimmunoelectrophoresis were used to characterise serologically Actinobacillus pleuropneumoniae isolates of serotypes 1, 9 and 11 using rabbit hyperimmune sera against serotypes 1 to 12. The rapid slide agglutination test using whole-cell suspension and the indirect haemagglutination test using whole-cell saline extract as antigens gave type specific reactions for serotypes 1 and 9. Antigens comprising saline extracts of boiled or autoclaved cells demonstrated common epitopes among the isolates of all three serotypes in the indirect haemagglutination test. Quantification of the type and group-specific antigens by the coagglutination test. Quantification of the type and group-specific antigens by the coagglutination test distinguished serotypes 1 and 9 strains from those of serotype 11. Results of absorption studies in immunodiffusion tests indicated that the cross-reactivity encountered among strains of serotypes 1, 9 and 11 might be due to common epitopes associated with cell-wall antigens. However, they certainly also have type-specific epitopes, possibly associated with superficially located, capsular antigens.

Actinobacillus Infections↗

Virulence of capsulated and noncapsulated isolates of Pasteurella multocida and their adherence to porcine respiratory tract cells and mucus.

The virulence and the adherence to porcine respiratory tract cells and mucus of three toxigenic, capsular type D Pasteurella multocida isolates and their noncapsulated variants were evaluated in the present study. Loss of capsule by P. multocida, verified by transmission electron microscopy after polycationic ferritin labeling, was associated with a massive reduction in virulence of the organisms in mice. Specific-pathogen-free piglets inoculated intranasally with one of the capsulated isolates or its noncapsulated variant developed turbinate lesions characterized by bone resorption and by an inflammation of the mucosa associated with hyperplasia and squamous metaplasia of the epithelium. Infection with the capsulated isolate led to more severe lesions and atrophy of turbinates. The interactions of these P. multocida isolates with porcine respiratory tract cells and mucus were studied in vitro. The presence of capsule resulted in a decrease in binding of respiratory tract mucus were studied in vitro. The presence of capsule resulted in a decrease in binding of respiratory tract mucus to P. multocida isolates as determined by a dot blot assay. The presence of capsule also resulted in a significant decrease in adherence to porcine tracheal rings maintained in culture. The capsule seemed to mask outer membrane components which are involved in adherence. One of these components might be lipopolysaccharide since purified lipopolysaccharide bound respiratory tract mucus and blocked adherence of this microorganism to porcine tracheal rings. Our data indicate that capsular material does not seem to be involved in adherence of P. multocida to respiratory tract cells and mucus, but capsulated isolates are more virulent in mice and also in piglets.

Animals↗

Mycoplasma hyopneumoniae infection in pigs: duration of the disease and resistance to reinfection.

Forty-eight hysterectomy produced piglets reared in a pathogen-free environment were housed in 4 separate units. Three groups were intratracheally challenged with M hyopneumoniae at 2 wk, or at 16 wk, or at 2 and 16 wk of age. The fourth group was uninfected and received broth medium. Coughing started 2 weeks after the first infection but the booster infection did not induce any coughing. Macroscopic lesions, typical of mycoplasmal pneumonia, were noted 1 wk post-infection. After 7-9 wk, piglets showed recovering lesions. In the group that was twice infected, only 1 pig had extensive pneumonia after the second infection. The remaining pigs only had recovering lesions (RL) (resulting from the first challenge). Histopathology and scanning electron microscopy confirmed the macroscopic observations. Antibodies were detected by ELISA and immunoblotting at 3-4 wk post-infection, peaking after 11-12 wk and then gradually decreasing. However, the antibody response increased after the second infection. These findings showed a noticeable recovery following infection with M hyopneumoniae and a clear resistance to pneumonia following the booster infection.

Animals↗